Your fact-checks will appear here
Research and initiatives for Alzheimer's disease, including diagnostics, trials, and data-sharing.
The short answer: no — there is no credible evidence that has discovered or endorsed a “cure” for dementia, and multiple fact-checkers and Carson’s own representatives have called the viral claims fal...
No — there is no evidence that Bill Gates and Dr. Sanjay Gupta discovered a cure for memory loss or Alzheimer’s disease: mainstream reporting at the time shows Gates pledged research funding and Gupta...
's public pitch for treating Alzheimer's centers on 's brain‑computer interface (BCI) as a possible revolutionary therapy, but the technology remains in early human testing with no published evidence ...
Elon Musk is not marketing or clinically producing a “cognitive decline medicine” in the conventional pharmaceutical sense; his high-profile activity in the field centers on Neuralink, a brain‑compute...
P7C3‑A20 has compelling and recent preclinical data showing restoration of NAD+ homeostasis and reversal of severe pathology in multiple animal models, but no human clinical trials of P7C3‑A20 were re...
A broad ecosystem of federal agencies, academic medical centers, advocacy groups, and pharmaceutical companies is actively running and sponsoring dementia trials ranging from early-phase biology and b...
has deployed a mix of personal philanthropy and partnership funding to accelerate diagnostics, drug discovery and data-sharing, including a $100 million personal commitment, a $50 million investment i...
Randomized-trial evidence for is limited and mixed, but the clearest randomized signal comes from (TBI) studies, whereas has encouraging human pilot data that are not randomized, and evidence is sugge...
is not running laboratory benches or clinical trials himself but has funneled substantial philanthropic capital and organizational muscle into , prioritizing , early detection and diagnostics, and nov...
Laboratory research in multiple labs has produced drugs and interventions that reverse and restore memory in mice, but no medication has yet been shown to in humans; current human therapies largely ai...
A search of the provided reporting shows "" as an aromatic substance tested for neuroprotective effects only in animal experiments—specifically in mice where it reduced stress-linked hippocampal degen...
Medically accepted causes of Alzheimer’s center on neurodegenerative changes — notably extracellular amyloid plaques and intracellular tau neurofibrillary tangles — and treatments today can only slow ...
Bee venom (BV) and its purified components—melittin, phospholipase A2 (bvPLA2), apamin—show anti-inflammatory, antioxidant and neuroprotective effects in laboratory models of neurodegeneration and neu...
The viral “Ben Carson honey recipe” that promises rapid reversal of memory loss is a promotional scam: major fact‑checkers found the endorsements and news articles tying Carson to miracle dementia cur...
The Government Accountability Office (GAO) has concluded that stronger, clearer oversight is needed for memory and Alzheimer’s dietary supplements and has urged federal agencies to take additional act...
There is no verified cure for Alzheimer’s disease today; major research organizations and recent reviews state treatments can slow or modestly alter disease progression but do not reverse it . Publici...
Dr. Sanjay Gupta approaches mental health as a broad public-health and brain‑health communicator, emphasizing prevention, lifestyle and access to care through media, moderation of expert forums and ed...
The FDA has accepted a supplemental New Drug Application (sNDA) for AXS‑05 to treat agitation in Alzheimer’s disease and granted Priority Review with a PDUFA action date of April 30, 2026, moving a co...